Search by name:
A B C D E F G H I J K L M N O P R S T U V W X Y Z
Diabetes
  • Glucophage
    $0.27

    Glucophage is an oral diabetes medicine used to treat type 2 of diabetes.


  • Glucotrol
    $0.27
    Glucotrol is sulfonylurea class of drugs, a drug used to treat type 2 of diabetes.
  • Actos
    $0.39
    Actos (Pioglitazone) is used to control high blood sugar in type 2 diabetes (non-insulin-dependent diabetes ...
  • DDAVP
    $4.04

    Generic DDAVP is used to prevent or control the frequent urination and loss of water caused by diabetes ...

  • Glucophage SR
    $0.72
    Glucophage SR is an oral diabetes medicine used to treat type 2 of diabetes.
  • Prandin
    $0.84
    Prandin is used to stimulate insulin secretion from the pancreas in treatment of type 2 of diabetes mellitus.
  • Precose
    $0.86
    Acarbose slows the digestion of carbohydrates in the body, which helps control blood sugar levels.
  • Amaryl
    $0.64
    Amaryl is an oral blood sugar-lowering drug which belongs to the class of sulfonylureas.
  • Glucotrol Xl
    $0.31
    Glucotrol Xl is sulfonylurea class of drugs, a drug used to treat type 2 of diabetes.
  • Glucovance
    $0.71
    Glucovance is a combination of two orally taken drugs possessing a hyproglycemic effect. Used to treat ...
  • Glycomet
    $1.03
    Glycomet is an oral diabetes medicine used to treat type 2 of diabetes.
  • Micronase
    $0.44
    Micronase contains glyburide, which lowers glucose levels in the blood.
  • Starlix
    $0.78
    Starlix (nateglinide) is an oral diabetes medicine that helps control blood sugar levels.
Payment Methods
Secure Payment Process
News
Why a faecal transplant could save your life
Patient's lives are being saved by poo, but how far can microbial medicine go?
Cystic fibrosis: Company urged to lower cost of life-changing drug
Health ministers call on company to lower price of cystic fibrosis drug Orkambi so the NHS can afford it.
Allied Healthcare: Home care provider seeks rescue plan
Allied Healthcare, one of the UK's biggest providers of in-home care, blames a "challenging environment".